0001104659-23-092542.txt : 20230816 0001104659-23-092542.hdr.sgml : 20230816 20230816160523 ACCESSION NUMBER: 0001104659-23-092542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230814 FILED AS OF DATE: 20230816 DATE AS OF CHANGE: 20230816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carter Eric G CENTRAL INDEX KEY: 0001387660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40021 FILM NUMBER: 231178222 MAIL ADDRESS: STREET 1: C/O KING PHARMACEUTICALS, INC. STREET 2: 501 FIFTH STREET CITY: BRISTOL STATE: TN ZIP: 37620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEON Biopharma, Inc. CENTRAL INDEX KEY: 0001837607 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853940478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 354-6499 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: Priveterra Acquisition Corp. DATE OF NAME CHANGE: 20201222 4 1 tm2323956-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-14 0 0001837607 AEON Biopharma, Inc. AEON 0001387660 Carter Eric G 5 PARK PLAZA, SUITE 1750 IRVINE CA 92614 1 0 0 0 0 Stock Option 5.47 2023-08-14 4 A 0 58851 0 A 2033-08-13 Common Stock 58851 58851 D Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date. /s/ Alexander Wilson, Attorney-in-Fact 2023-08-16